Skip to content
Lower risk Medical device recall · FDA · Published August 9, 2021

Beckman Coulter Access hsTnI Troponin I Reagent Pack Recall: Carryover Risk

Beckman Coulter recalls Access hsTnI High Sensitivity Troponin I reagent packs with specific lot numbers due to potential sample carryover causing contamination in high concentration tests.

🇺🇸 FDA recall #Z-0032-2022Medical deviceBeckman Coulter ›
Take action

Contact the company

Recalling firmBeckman Coulter Inc.250 S Kraemer Blvd · Brea, CA 92821-6232
✎ GovInfoNow plain-language explainer

Beckman Coulter is recalling certain Access hsTnI High Sensitivity Troponin I reagent packs. Using these packs with very high troponin I concentrations may cause contamination that affects test results. This could lead to inaccurate cardiac tests if not addressed. Read more at govinfonow.com/recall/62008-beckman-coulter-access-hstni-troponin-i-reagent-pack-recall-carryover.

Source Summary by GovInfoNow · govinfonow.com/recall/62008-beckman-coulter-access-hstni-troponin-i-reagent-pack-recall-carryover · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0032-2022

Cite this page

“Beckman Coulter Access hsTnI Troponin I Reagent Pack Recall: Carryover Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62008-beckman-coulter-access-hstni-troponin-i-reagent-pack-recall-carryover. Based on FDA recall #Z-0032-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0032-2022%22&limit=1).

The FDA announced on Aug. 9, 2021, that Beckman Coulter Inc. is recalling Access hsTnI High Sensitivity Troponin I reagent packs due to potential sample carryover hazards. The agency issued recall number Z-0032-2022 for the device.

How to tell if you have it

  • Brand: Beckman Coulter
  • Product: Access hsTnI High Sensitivity Troponin I, REF B52699 Access Immunoassay System REAGENT PACK
  • UPC: 15099590693183
  • Lot Numbers: 921491, 921638, 921631, 921750, 921805, 921831, 921943, 922000, 922039, 922040, 922062, 922145, 922146, 922338, 922440, 922545, 922547, 922713, 922714, 922722, 922897, 124235, 124339, 922898, 124340, 124348, 124353, 124688, 124354, 124355, 124356, 124357
  • Quantity: 293,640 kits

The hazard

According to the FDA, testing a sample with cardiac troponin I concentration greater than 270,000 pg/mL may cause carryover into the hsTnI reagent pack. This carryover occurs predominantly into the particle well of the reagent pack via the probe, contaminating it with the high sample. The extent of the carryover depends on sample concentration and frequency.

Context

GovInfoNow's records show Beckman Coulter has 133 other recalls on record since June 20, 2017. Other recent recalls include DxC 500 AU Clinical Chemistry Analyzers (Sept. 2, 2026), DxC 500i Modules with Software 1.5 Risk (July 15, 2026), and MicroScan LabPro V5.03 Panel Update 11 (June 26, 2026). Other recent recalls of similar products include Emit 2000 Quinidine Assay Recall (July 13, 2026) and Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (July 13, 2026).

How to tell if you have this one

Check the lot number on the reagent pack. The affected lots include 921491, 921638, 921631, 921750, 921805, 921831, 921943, 922000, 922039, 922040, 922062, 922145, 922146, 922338, 922440, 922545, 922547, 922713, 922714, 922722, 922897, 124235, 124339, 922898, 124340, 124348, 124353, 124688, 124354, 124355, 124356, 124357.

  • Brand
    Beckman Coulter
  • Product
    Beckman Coulter Inc. recalls Access hsTnI High Sensitivity Troponin I, REF B52699 Access Immunoassay System REAGENT PACK
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Reagent Lot Number

    Look for the lot number on the reagent pack to determine if it is affected. Affected lots are listed in the recall.

Where it went and when

Where it was distributed

Distributed in 43 states and D.C. and Puerto Rico, and outside the U.S.

Alaska: not listedAKMaine: yesMEVermont: not listedVTNew Hampshire: not listedNHWashington: yesWAIdaho: yesIDMontana: not listedMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: not listedMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: not listedUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: not listedNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “U.S.: AL, AR, AZ, CA, CO, CT, DE, DC, FL, GA, Guam, HI, IA, ID, IL, IN, KS, KY, LA, ME, MD, MI, MN, MS, MO, NC, ND, NE, NV, NJ, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, VA, WA, WI, WV, and WY O.U.S.: Algeria, Andorra,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Aug 9, 202112. FDA classified it Class II: Oct 5, 202123. Published in FDA’s Enforcement Report: Oct 13, 202132021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0032-2022 (August 9, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0032-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA